Skip to content

Clinical trials

Obesity trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Country / region: Italy Clear all

331 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20043
20055
20063
20073
20098
20105
20119
20128
201314
20149
201515
201611
201710
201813
201921
202019
202126
202231
202329
202434
202525
202624

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed166
Recruiting68
Unknown status59
Active, not recruiting16
Not yet recruiting11
Terminated8
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Istituto Auxologico Italiano38
Novo Nordisk A/S21
University of Roma La Sapienza21
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis14
Federico II University13
Fondazione Policlinico Universitario Agostino Gemelli IRCCS12
Eli Lilly and Company10
Azienda Ospedaliero Universitaria Maggiore della Carita8
Catholic University of the Sacred Heart7
IRCCS Azienda Ospedaliero-Universitaria di Bologna6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity331
Overweight82
Diabetes Mellitus, Type 234
Non-alcoholic Fatty Liver Disease21
Weight Loss21
Metabolic Syndrome17
Hypertension16
Insulin Resistance16
Diabetes Mellitus15
Obesity, Morbid15

Trials

Showing 51 to 75 of 331. Each trial links to its page on Pharma Observatory.

231 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.